The pharmacy benefit manager (PBM) industry is under pressure to shift to models that avoid conflicts of interest and ...

Current treatment options have improved survival rates but have not provided a cure. Eventually, initial therapies stop ...

While heritable human genome editing is banned in the United States, across Europe and much of the world, the technology ...

Although 52% of healthcare leaders believe a fatal cyber-related patient incident will happen within the next five years, ...

The Teal Wand was recently approved by the FDA as the first self-collection device to screen for cervical cancer, a major step forward for accessible women’s health, according to Rahma S. Mkuu, Ph.D., ...

As researchers continue to explore more effective solutions, combining platelet-rich plasma (PRP) with fractional laser therapy has gained increasing attention.

Jeffrey Casberg, M.S., of IPD Analytics and Luke Greenwalt, MBA, of IQVIA, both members of the Managed Healthcare Executive (MHE) editorial advisory board, will provide a midyear assessment of the ...

The approval is based on results from the phase 3 ARANOTE trial, which showed Nubeqa, when combined with androgen deprivation ...

Researchers at MD Anderson discussed the five possible approaches to treating graft-versus-host disease in a review article ...

Medicare Advantage plans have drawn the ire of lawmakers for aggressive coding. Investigations are underway. Some hope ...

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

Satellos Bioscience Chief Scientific Officer discusses early-stage trials of the company's Duchenne muscular dystrophy drug, ...